Document is current

Article History

Accepted: 23 August 2021

First Online: 11 October 2021

Declarations

:

: Funding for this publication and editorial support was provided by Teva Pharmaceutical Industries, West Chester, PA, USA.

: John M. Kane has been a consultant for or received honoraria from Alkermes, Intra-Cellular Therapies, Janssen, Johnson and Johnson, Karuna, LB Pharmaceuticals, Lundbeck, Lyndra, Merck, Neurocrine Biosciences, Otsuka, Pierre Fabre, Reviva, Roche, Saladex, Sunovion, Takeda, and Teva Pharmaceutical Industries; has received grant support from Otsuka, Lundbeck, and Janssen; and is a shareholder of LB Pharmaceuticals and Vanguard Research Group. Joseph P. McEvoy has received grant/research support from Alkermes, Auspex Pharmaceuticals (Teva Pharmaceutical Industries), Biogen, Boehringer Ingelheim, Lundbeck, and Takeda and has served on advisory boards for Intra-Cellular Therapies and Sunovion. Christoph U. Correll has been a consultant for or has received honoraria from AbbVie, Acadia Pharmaceuticals, Alkermes, Allergan, Angelini, Axsome Therapeutics, Gedeon Richter, Intra-Cellular Therapies, Janssen, Johnson & Johnson, Karuna, LB Pharmaceuticals, Laboratorios Farmacéuticos ROVI, Lundbeck, MedAvante-ProPhase, MedInCell, Medscape, Merck, Mitsubishi Tanabe Pharma, Mylan, Neurocrine, Noven, Otsuka, Pfizer, Recordati, Seqirus, Servier, Sumitomo Dainippon, Sunovion, Supernus Pharmaceuticals, Takeda, Teva Pharmaceutical Industries, and Viatris; has provided expert testimony for Janssen and Otsuka; has served on data safety monitoring boards or advisory boards for Laboratorios Farmacéuticos ROVI, Lundbeck, Supernus, and Teva Pharmaceutical Industries; has received grant support from Janssen and Takeda; has received royalties from UpToDate; serves on the board of directors for the American Society of Clinical Psychopharmacology; and is a shareholder of LB Pharmaceuticals. Pierre-Michel Llorca has been a consultant for or has received honoraria from AbbVie, Allergan, Eisai, Gedeon Richter, Janssen, Lundbeck, Otsuka, Sanofi, and Teva Pharmaceutical Industries; has received travel support from Eisai, Lundbeck, and Janssen; has served on data safety monitoring boards or advisory boards for AbbVie, Allergan, Eisai, Janssen, Lundbeck, Otsuka, Sanofi, and Teva Pharmaceutical Industries; and has received grant support from and provided expert testimony for Janssen.

: Not applicable.

: Not applicable

: Not applicable

: Not applicable

: All authors contributed equally to the conception, literature review, drafting, and review processes related to this publication. All authors approved the final version of the manuscript for submission and agree to be accountable for the information presented in this publication.